A pilot trial of irinotecan, 5-fluorouracil, and leucovorin [folinic acid] combined with the anti-angiogenesis agent tetrathiomolybdate in metastatic colorectal carcinoma (UMCC 0075)

Trial Profile

A pilot trial of irinotecan, 5-fluorouracil, and leucovorin [folinic acid] combined with the anti-angiogenesis agent tetrathiomolybdate in metastatic colorectal carcinoma (UMCC 0075)

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 05 Feb 2012

At a glance

  • Drugs Tetrathiomolybdate (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top